Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity

Jin Feng1, Chao Huang2, Jonathan D Wren3

  • 1Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

Cancer Metastasis Reviews
|September 4, 2015
PubMed

Insights

Tetraspanin CD82, a protein that suppresses solid tumors, also impacts cell migration and invasion. Its role in hematopoietic malignancies requires further investigation for potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Tetraspanin CD82 is known to suppress solid tumor progression and metastasis.
  • The specific roles of CD82 in tumorigenesis and hematopoietic malignancies are not well understood.

Purpose of the Study:

  • To elucidate the functions of Tetraspanin CD82 in tumorigenesis and metastasis.
  • To explore CD82's potential as a therapeutic target for cancer treatment.

Main Methods:

  • Investigating CD82's modulation of cell-matrix and cell-cell adhesion.
  • Analyzing CD82's impact on cell migration and invasion pathways.
  • Examining CD82's role in cell membrane organization and heterogeneity.

Main Results:

  • CD82 restrains cell migration and invasion by altering cell adhesion and pro-motility signaling.
  • CD82 modulates cell membrane heterogeneity, affecting molecular landscape, trafficking, and topography.
  • Changes in membrane properties influenced by CD82 impact cellular functions and cytoskeletal interactions.

Conclusions:

  • CD82's metastasis-suppressive activity is linked to its ability to restrain cell movement.
  • CD82 is a significant factor in cell membrane organization and heterogeneity.
  • CD82 holds promise for predicting and blocking tumor progression and metastasis, and serves as a model for understanding cell membrane dynamics.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K